Distinct Subgroups and Outcomes in Patients With Hypertrophic Obstructive Cardiomyopathy After Septal Myectomy

Siyu Zhang1, Qiuchen Yuan2, Zitian Zhu2

  • 1Department of Cardiovascular Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College Fuwai Hospital, Beijing, China.

PubMed

Insights

This study identified three subgroups of hypertrophic obstructive cardiomyopathy (HOCM) patients. Older patients with enlarged left atrial diameter face higher risks, while younger patients have increased arrhythmia risk, informing personalized HOCM care.

Area of Science:

  • Cardiology
  • Medical Subspecialties
  • Internal Medicine

Background:

  • Hypertrophic obstructive cardiomyopathy (HOCM) is a complex condition with varied patient outcomes.
  • Septal myectomy offers symptomatic relief, but predicting individual postoperative risks and long-term prognosis remains challenging.

Purpose of the Study:

  • To identify distinct patient subgroups within HOCM using latent class analysis.
  • To compare postoperative and long-term outcomes among identified subgroups.
  • To develop a simplified clinical classification tool for HOCM patients.

Main Methods:

  • Retrospective analysis of 699 HOCM patients.
  • Latent class analysis to define patient subgroups.
  • Decision tree model for simplified clinical classification.

Main Results:

  • Three HOCM subgroups were identified: younger patients (Group 1), older patients with smaller left atrial diameter (LAD) (Group 2), and older patients with enlarged LAD (Group 3).
  • Group 3 exhibited significantly higher risks of postoperative complications (atrial fibrillation, prolonged ventilation, renal failure) and adverse long-term outcomes (mortality, cardiac readmission, major adverse cardiac and cerebrovascular events).
  • Group 1 showed the highest risk of ventricular arrhythmias. A decision tree using age and LAD achieved 95.7% classification accuracy.

Conclusions:

  • Latent class analysis effectively stratified HOCM patients into distinct risk groups.
  • Older patients with enlarged LAD represent the highest cardiovascular risk group.
  • Younger patients are at increased risk for arrhythmias, necessitating tailored surveillance and management strategies.
Abstract

Related Concept Videos

Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
251
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
360
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
310
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
422
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
431
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
471